市場調査レポート

商品コード

シングルセル解析の世界市場：用途別、細胞タイプ別、エンドユーザー別、製品別、手法別、地域別 - 2030年までの予測

Single Cell Analysis Market by Product (Consumables, Instruments), Cell Type, Technique, Application (Research, Medical ) - Global Forecast to 2030

出版日: 2025年05月07日
発行: MarketsandMarkets
ページ情報: 英文 518 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 4,950 723,096円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (5-user License)

USD 6,650 971,432円

レポートPDFを同じ国内の同じ事業所内の5名迄にて共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate License)

USD 8,150 1,190,552円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありませんが、同一国内にある事業所のみとなり、海外支店などは含まれません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global License)

USD 10,000 1,460,800円

レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。100％子会社は同一企業とみなされます。PDF内のテキスト等のコピー＆ペースト可能です。PDの印刷は何回でも可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

シングルセル解析の市場規模は、2025年の38億1,000万米ドルから2030年には75億6,000万米ドルに達すると予測され、予測期間中のCAGRは14.7%になるとみられています。

この市場成長は、個別化医療が重視されるようになったことが大きな要因です。製薬業界やバイオテクノロジー業界における研究開発投資の増加も、シングルセル解析の拡大に寄与しています。さらに、幹細胞研究の増加やシングルセル解析技術の進歩などの要因が市場をさらに押し上げると予想されます。さらに、がんの罹患率の上昇が先進的な治療に対する需要を生み出しており、これがシングルセル解析市場の成長を促進すると予測されています。先進的なシングルセルシーケンス技術の採用が増加していることも、今後数年間の市場成長を促進すると予想されます。

調査範囲
調査対象年	2024年～2030年
基準年	2024年
予測期間	2024年～2030年
検討単位	金額（10億米ドル）
セグメント	用途別、細胞タイプ別、エンドユーザー別、製品別、手法別、地域別
対象地域	北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ

シングルセル解析市場は、用途によって研究用途と医療用途の2つに大別されます。研究用途セグメントには、がん研究、免疫学研究、神経学研究、幹細胞研究、その他関連分野など様々な分野が含まれます。一方、医療用途分野はさらに、非侵襲的出生前診断、体外受精、循環腫瘍細胞検出などに分けられます。

2024年には、研究用途分野が世界のシングルセル解析市場で最大のシェアを占めました。がんの有病率の増加が先進的な治療への需要を促進しており、これがこのセグメントの成長に寄与しています。さらに、幹細胞研究の拡大もシングルセル解析市場の成長をさらに押し上げると見られています。

シングルセル解析市場は、技術に基づいてフローサイトメトリー、次世代シーケンシング、ポリメラーゼ連鎖反応、顕微鏡、質量分析、その他の技術に分類されます。2024年には、フローサイトメトリーセグメントが世界の技術別シングルセル解析市場で最大の貢献者となっています。この著しい成長は主に、不均一な混合物内で複数の測定を実行できるフローサイトメトリーがシングルセル解析に広く使用されているためです。さらに、高度な細胞同定および特性解析技術の採用が増加していることが、シングルセル解析市場のこのセグメントの成長をさらに促進すると予想されます。

シングルセル解析市場は大きく6つの地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）に分けられます。2024年、北米では米国がこの市場を独占しました。世界最大のバイオ医薬品市場として、米国はバイオ医薬品の研究と投資をリードしています。その強固なヘルスケア・インフラは、ライフサイエンス分野の研究開発をさらに後押ししています。さらに、多数のバイオ医薬品企業が存在し、バイオテクノロジー産業における研究活動が活発化していることも、米国の市場成長に寄与しています。さらに、がん罹患率の上昇を背景とした個別化医療開発への注目の高まりも、シングルセル解析市場の成長を後押ししています。

当レポートでは、世界のシングルセル解析市場について調査し、用途別、細胞タイプ別、エンドユーザー別、製品別、手法別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

イントロダクション
市場力学
顧客ビジネスに影響を与える動向/混乱
バリューチェーン分析
エコシステム分析
技術分析
特許分析
貿易分析
ポーターのファイブフォース分析
関税と規制状況
価格分析
2025年～2026年の主な会議とイベント
主要な利害関係者と購入基準
投資と資金調達のシナリオ
生成AIがシングルセル解析市場に与える影響
ケーススタディ分析
米国の2025年関税の影響概要

第6章シングルセル解析市場（用途別）

イントロダクション
研究
医療

第7章シングルセル解析市場（細胞タイプ別）

イントロダクション
ヒトの細胞
動物細胞
微生物細胞

第8章シングルセル解析市場（エンドユーザー別）

イントロダクション
学術研究室
バイオテクノロジーおよび製薬会社
病院および診断検査室
細胞バンクと体外受精センター

第9章シングルセル解析市場（製品別）

イントロダクション
消耗品
機器

第10章シングルセル解析市場（手法別）

イントロダクション
フローサイトメトリー
次世代シーケンシング
ポリメラーゼ連鎖反応
顕微鏡検査
質量分析
その他

第11章シングルセル解析市場（地域別）

イントロダクション
北米
- 北米のマクロ経済見通し
- 米国
- カナダ
欧州
- 欧州のマクロ経済見通し
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他
アジア太平洋
- アジア太平洋のマクロ経済見通し
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- その他
ラテンアメリカ
- ラテンアメリカのマクロ経済見通し
- ブラジル
- メキシコ
- その他
中東
- 中東のマクロ経済見通し
- GCC
- その他
アフリカ
- バイオ医薬品の開発と生産への資金増加が市場を牽引
- アフリカのマクロ経済見通し

第12章競合情勢

概要
主要参入企業の戦略/強み、2021年～2025年
収益分析、2022年～2024年
市場シェア分析、2024年
企業評価マトリックス：主要参入企業、2024年
企業評価マトリックス：スタートアップ/中小企業、2023年
企業評価と財務指標
ブランド/製品比較
競合シナリオ

第13章企業プロファイル

イントロダクション
主要参入企業
- BD
- THERMO FISHER SCIENTIFIC INC.
- DANAHER CORPORATION
- 10X GENOMICS
- MERCK KGAA
- AGILENT TECHNOLOGIES, INC.
- QIAGEN
- ILLUMINA, INC.
- BIO-RAD LABORATORIES, INC.
- DIASORIN S.P.A.
- STANDARD BIOTOOLS
- TECAN TRADING AG
- SARTORIUS AG
- CORNING INCORPORATED
- CYTEK BIOSCIENCES
- TAKARA BIO INC.
- BIOMERIEUX
- REVVITY
- BIO-TECHNE
- PACBIO
- BRUKER
- PROMEGA CORPORATION
- OXFORD NANOPORE TECHNOLOGIES PLC
その他の企業
- SINGLERON BIOTECHNOLOGIES
- CELL MICROSYSTEMS
- NANOCELLECT BIOMEDICAL
- RARECYTE, INC.
- BICO
- MENARINI GROUP
- APOGEE FLOW SYSTEMS LTD
- CREATIVE BIOLABS
- SPHERE BIO
- YOKOGAWA ELECTRIC CORPORATION

第14章付録

図表

List of Tables

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS
TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES
TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
TABLE 5 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
TABLE 6 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019-2025
TABLE 7 SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS
TABLE 8 SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS
TABLE 9 SINGLE-CELL ANALYSIS MARKET: END USERS
TABLE 10 SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES
TABLE 11 APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS
TABLE 12 TYPES OF BIOINFORMATICS TOOLS
TABLE 13 PATENTS FILED, 2014-2024
TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2023-2024
TABLE 15 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND)
TABLE 16 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (TONS)
TABLE 17 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND)
TABLE 18 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (TONS)
TABLE 19 SINGLE-CELL ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES
TABLE 25 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022-2024
TABLE 26 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
TABLE 27 SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
TABLE 28 BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER
TABLE 29 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 30 KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS AND ELECTRICAL MACHINERY AND EQUIPMENT AND PARTS THEREOF
TABLE 31 CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES
TABLE 32 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 33 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 34 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 35 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 36 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 38 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 39 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 40 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 41 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2023-2030 (USD MILLION)
TABLE 42 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 43 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 45 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 46 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 47 GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 48 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2023-2030 (USD MILLION)
TABLE 49 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 50 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 51 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 52 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 53 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 54 GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 55 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2023-2030 (USD MILLION)
TABLE 56 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 57 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 58 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 59 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 60 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 61 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 62 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
TABLE 63 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 64 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 65 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 66 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 67 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 68 GCC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 69 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 70 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 71 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 72 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 73 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 74 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 75 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 76 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 77 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 78 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 79 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 80 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 81 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 82 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 83 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 84 SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2023-2030 (USD MILLION)
TABLE 85 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 86 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 87 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 88 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 89 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 90 GCC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 91 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2023-2030 (USD MILLION)
TABLE 92 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 93 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 94 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 95 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 96 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 97 GCC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 98 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 99 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 100 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 101 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 102 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 103 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 104 GCC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 105 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 106 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2023-2030 (USD MILLION)
TABLE 107 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 108 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 109 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 110 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 111 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 112 GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 113 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2023-2030 (USD MILLION)
TABLE 114 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 115 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 116 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 117 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 118 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 119 GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 120 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2023-2030 (USD MILLION)
TABLE 121 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 122 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 123 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 124 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 125 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 126 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 127 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 128 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 129 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 130 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 131 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 132 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 133 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 134 GCC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 135 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 136 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 137 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 138 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 139 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 140 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 141 GCC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 142 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 143 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 144 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 145 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 146 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 147 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 148 GCC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 149 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 150 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 151 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 152 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 153 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 154 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 155 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 156 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 157 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 158 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2023-2030 (USD MILLION)
TABLE 159 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 160 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 161 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 162 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 163 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 164 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 165 SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION, 2023-2030 (USD MILLION)
TABLE 166 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 167 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 168 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 169 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 170 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 171 GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 172 SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION, 2023-2030 (USD MILLION)
TABLE 173 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 174 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 175 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 176 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 177 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 178 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 179 SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 180 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 181 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 182 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 183 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 184 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 185 GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 186 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 187 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION, 2023-2030 (USD MILLION)
TABLE 188 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 189 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 190 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 191 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 192 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 193 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 194 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2023-2030 (USD MILLION)
TABLE 195 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 196 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 197 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 198 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 199 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 200 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 201 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2023-2030 (USD MILLION)
TABLE 202 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 203 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 204 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 205 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 206 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 207 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 208 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2023-2030 (USD MILLION)
TABLE 209 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 210 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 211 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 212 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 213 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 214 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 215 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 216 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 217 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 218 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 219 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 220 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 221 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 222 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 223 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 224 NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 225 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 226 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 227 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 228 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 229 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 230 SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
TABLE 231 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 232 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 233 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 234 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 235 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 236 GCC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 237 SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 238 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 239 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 240 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 241 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 242 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 243 GCC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 244 SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 245 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 246 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 247 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 248 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 249 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 250 GCC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 251 SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 252 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 253 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 254 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 255 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 256 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 257 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 258 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY REGION, 2023-2030 (USD MILLION)
TABLE 259 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 260 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 261 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 262 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 263 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 264 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 265 SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
TABLE 266 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 267 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 268 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 269 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 270 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 271 GCC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 272 SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY REGION, 2023-2030 (USD MILLION)
TABLE 273 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 274 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 275 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 276 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 277 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 278 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 279 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 280 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 281 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 282 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 283 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 284 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 285 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 286 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 287 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 288 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 289 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 290 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 291 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 292 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 293 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 294 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2023-2030 (USD MILLION)
TABLE 295 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 296 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 297 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 298 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 299 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 300 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 301 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 302 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 303 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 304 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 305 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 306 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 307 GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 308 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2023-2030 (USD MILLION)
TABLE 309 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 310 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 311 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 312 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 313 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 314 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 315 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 316 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 317 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 318 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 319 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 320 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 321 GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 322 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2023-2030 (USD MILLION)
TABLE 323 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 324 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 325 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 326 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 327 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 328 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 329 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 330 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 331 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 332 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 333 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 334 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 335 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 336 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 337 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 338 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 339 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 340 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 341 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 342 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 343 US: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 344 US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 345 US: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 346 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 347 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 348 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 349 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 350 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 351 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 352 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 353 CANADA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 354 CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 355 CANADA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 356 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 357 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 358 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 359 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 360 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 361 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 362 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 363 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 364 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 365 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 366 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 367 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 368 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 369 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 370 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 371 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 372 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 373 EUROPE: MACROECONOMIC INDICATORS
TABLE 374 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 375 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 376 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 377 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 378 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 379 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 380 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 381 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 382 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 383 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 384 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 385 UK: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 386 UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 387 UK: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 388 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 389 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 390 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 391 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 392 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 393 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 394 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 395 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 396 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 397 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 398 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 399 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 400 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 401 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 402 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 403 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 404 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 405 ITALY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 406 ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 407 ITALY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 408 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 409 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 410 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 411 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 412 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 413 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 414 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 415 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 416 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 417 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 418 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 419 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 420 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 421 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 422 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 423 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 424 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 425 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 426 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 427 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 428 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 429 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 430 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 431 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 432 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 433 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 434 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 435 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 436 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 437 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 438 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 439 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 440 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 441 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 442 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 443 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 444 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 445 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 446 CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 447 CHINA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 448 CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 449 CHINA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 450 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 451 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 452 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 453 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 454 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 455 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 456 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 457 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 458 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 459 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 460 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 461 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 462 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 463 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 464 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 465 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 466 INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 467 INDIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 468 INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 469 INDIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 470 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 471 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 472 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 473 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 474 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 475 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 476 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 477 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 478 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 479 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 480 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 481 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 482 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 483 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 484 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 485 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 486 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 487 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 488 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 489 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 490 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 491 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 492 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 493 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 494 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 495 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 496 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 497 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 498 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 499 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 500 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 501 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 502 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 503 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 504 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 505 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 506 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 507 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 508 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 509 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 510 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 511 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 512 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 513 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 514 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 515 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 516 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 517 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 518 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 519 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 520 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 521 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 522 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 523 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 524 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 525 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 526 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 527 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 528 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 529 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 530 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 531 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 532 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 533 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 534 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 535 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 536 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 537 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 538 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 539 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 540 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 541 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 542 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 543 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 544 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 545 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 546 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 547 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 548 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 549 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 550 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 551 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 552 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 553 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 554 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 555 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 556 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 557 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 558 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 559 MIDDLE EAST: MACROECONOMIC INDICATORS
TABLE 560 GCC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 561 GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 562 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 563 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 564 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 565 GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 566 GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 567 GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 568 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 569 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 570 GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 571 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 572 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 573 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 574 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 575 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 576 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 577 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 578 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 579 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 580 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 581 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 582 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 583 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 584 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 585 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 586 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 587 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 588 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 589 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 590 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 591 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 592 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 593 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 594 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 595 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 596 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 597 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 598 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 599 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 600 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 601 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 602 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 603 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 604 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 605 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 606 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 607 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 608 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 609 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 610 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 611 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 612 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 613 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 614 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 615 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION)
TABLE 616 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
TABLE 617 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 618 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 619 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 620 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 621 MACROECONOMIC OUTLOOK FOR AFRICA
TABLE 622 SINGLE-CELL ANALYSIS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021-2025
TABLE 623 SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION
TABLE 624 SINGLE-CELL ANALYSIS MARKET: PRODUCT FOOTPRINT
TABLE 625 SINGLE-CELL ANALYSIS MARKET: REGION FOOTPRINT
TABLE 626 SINGLE-CELL ANALYSIS MARKET: TECHNIQUE FOOTPRINT
TABLE 627 SINGLE-CELL ANALYSIS MARKET: APPLICATION FOOTPRINT
TABLE 628 SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 629 SINGLE-CELL ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 630 SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 631 SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2021-APRIL 2025
TABLE 632 SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2021-APRIL 2025
TABLE 633 BD: COMPANY OVERVIEW
TABLE 634 BD: PRODUCTS OFFERED
TABLE 635 BD: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 636 BD: DEALS, JANUARY 2021-APRIL 2025
TABLE 637 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 638 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 639 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 640 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-APRIL 2025
TABLE 641 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 642 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 643 DANAHER CORPORATION: DEALS, JANUARY 2021-APRIL 2025
TABLE 644 10X GENOMICS: COMPANY OVERVIEW
TABLE 645 10X GENOMICS: PRODUCTS OFFERED
TABLE 646 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 647 10X GENOMICS: DEALS, JANUARY 2021-APRIL 2025
TABLE 648 MERCK KGAA: COMPANY OVERVIEW
TABLE 649 MERCK KGAA: PRODUCTS OFFERED
TABLE 650 MERCK KGAA: DEALS, JANUARY 2021-APRIL 2025
TABLE 651 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 652 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 653 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 654 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-APRIL 2025
TABLE 655 QIAGEN: COMPANY OVERVIEW
TABLE 656 QIAGEN: PRODUCTS OFFERED
TABLE 657 QIAGEN: DEALS, JANUARY 2021-APRIL 2025
TABLE 658 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 659 ILLUMINA, INC.: PRODUCTS OFFERED
TABLE 660 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 661 ILLUMINA, INC.: DEALS, JANUARY 2021-APRIL 2025
TABLE 662 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 663 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 664 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 665 DIASORIN S.P.A.: COMPANY OVERVIEW
TABLE 666 DIASORIN S.P.A.: PRODUCTS OFFERED
TABLE 667 DIASORIN S.P.A.: DEALS, JANUARY 2021-APRIL 2025
TABLE 668 STANDARD BIOTOOLS: COMPANY OVERVIEW
TABLE 669 STANDARD BIOTOOLS: PRODUCTS OFFERED
TABLE 670 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 671 STANDARD BIOTOOLS: DEALS, JANUARY 2021-APRIL 2025
TABLE 672 TECAN TRADING AG: COMPANY OVERVIEW
TABLE 673 TECAN TRADING AG: PRODUCTS OFFERED
TABLE 674 TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 675 TECAN TRADING AG: DEALS, JANUARY 2021-APRIL 2025
TABLE 676 SARTORIUS AG: COMPANY OVERVIEW
TABLE 677 SARTORIUS AG: PRODUCTS OFFERED
TABLE 678 SARTORIUS AG: DEALS, JANUARY 2021-APRIL 2025
TABLE 679 SARTORIUS AG: EXPANSIONS, JANUARY 2021-APRIL 2025
TABLE 680 CORNING INCORPORATED: COMPANY OVERVIEW
TABLE 681 CORNING INCORPORATED: PRODUCTS OFFERED
TABLE 682 CYTEK BIOSCIENCES: COMPANY OVERVIEW
TABLE 683 CYTEK BIOSCIENCES: PRODUCTS OFFERED
TABLE 684 CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 685 CYTEK BIOSCIENCES: DEALS, JANUARY 2021-APRIL 2025
TABLE 686 CYTEK BIOSCIENCES: EXPANSIONS, JANUARY 2021-APRIL 2025
TABLE 687 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 688 TAKARA BIO INC.: PRODUCTS OFFERED
TABLE 689 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 690 TAKARA BIO INC.: DEALS, JANUARY 2021-APRIL 2025
TABLE 691 BIOMERIEUX: COMPANY OVERVIEW
TABLE 692 BIOMERIEUX: PRODUCTS OFFERED
TABLE 693 BIOMERIEUX: DEALS, JANUARY 2021-APRIL 2025
TABLE 694 REVVITY: COMPANY OVERVIEW
TABLE 695 REVVITY: PRODUCTS OFFERED
TABLE 696 REVVITY: DEALS, JANUARY 2021-APRIL 2025
TABLE 697 BIO-TECHNE: COMPANY OVERVIEW
TABLE 698 BIO-TECHNE: PRODUCTS OFFERED
TABLE 699 BIO-TECHNE: DEALS
TABLE 700 PACBIO: COMPANY OVERVIEW
TABLE 701 PACBIO: PRODUCTS OFFERED
TABLE 702 PACBIO: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 703 BRUKER: COMPANY OVERVIEW
TABLE 704 BRUKER: PRODUCTS OFFERED
TABLE 705 BRUKER: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
TABLE 706 BRUKER: DEALS, JANUARY 2021-APRIL 2025
TABLE 707 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 708 PROMEGA CORPORATION: PRODUCTS OFFERED
TABLE 709 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
TABLE 710 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS OFFERED
TABLE 711 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2021-APRIL 2025
TABLE 712 SINGLERON BIOTECHNOLOGIES: COMPANY OVERVIEW
TABLE 713 CELL MICROSYSTEMS: COMPANY OVERVIEW
TABLE 714 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW
TABLE 715 RARECYTE, INC.: COMPANY OVERVIEW
TABLE 716 BICO: COMPANY OVERVIEW
TABLE 717 MENARINI GROUP: COMPANY OVERVIEW
TABLE 718 APOGEE FLOW SYSTEMS LTD: COMPANY OVERVIEW
TABLE 719 CREATIVE BIOLABS: COMPANY OVERVIEW
TABLE 720 SPHERE BIO: COMPANY OVERVIEW
TABLE 721 YOKOGAWA ELECTRIC CORPORATION: COMPANY OVERVIEW

List of Figures

FIGURE 1 SINGLE-CELL ANALYSIS MARKET: RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET
FIGURE 3 SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024
FIGURE 5 ILLUSTRATIVE EXAMPLE OF BD COMPANY: REVENUE ANALYSIS, 2024
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 8 SINGLE-CELL ANALYSIS MARKET: CAGR PROJECTIONS
FIGURE 9 DATA TRIANGULATION METHODOLOGY
FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)
FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 15 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET
FIGURE 16 GROWTH IN STEM CELL RESEARCH TO DRIVE MARKET
FIGURE 17 HUMAN CELLS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2024
FIGURE 18 CONSUMABLES SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2025
FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN MEN AND WOMEN, 2022
FIGURE 23 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2014-2028
FIGURE 24 SHARE OF PERSONALIZED MEDICINE IN FDA'S NEW DRUG APPROVALS, 2015-2023
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 26 SINGLE-CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
FIGURE 27 SINGLE-CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
FIGURE 28 PATENT APPLICATIONS IN SINGLE-CELL ANALYSIS MARKET, JANUARY 2014-DECEMBER 2024
FIGURE 29 SINGLE-CELL ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
FIGURE 32 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, 2023-2030 (THOUSAND UNITS)
FIGURE 33 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
FIGURE 34 NIH FUNDING FOR STEM CELL RESEARCH, 2015-2025
FIGURE 35 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2022-2024
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 38 RANKING OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2024
FIGURE 39 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 40 SINGLE-CELL ANALYSIS MARKET: COMPANY FOOTPRINT
FIGURE 41 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023
FIGURE 42 EV/EBITDA OF KEY VENDORS
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 44 SINGLE-CELL ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 45 BD: COMPANY SNAPSHOT (2024)
FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 48 10X GENOMICS: COMPANY SNAPSHOT (2024)
FIGURE 49 MERCK KGAA: COMPANY SNAPSHOT (2024)
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 51 QIAGEN: COMPANY SNAPSHOT (2024)
FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 54 DIASORIN S.P.A.: COMPANY SNAPSHOT (2024)
FIGURE 55 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2024)
FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT (2024)
FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2024)
FIGURE 58 CORNING INCORPORATED: COMPANY SNAPSHOT (2024)
FIGURE 59 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)
FIGURE 60 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
FIGURE 61 BIOMERIEUX: COMPANY SNAPSHOT (2024)
FIGURE 62 REVVITY: COMPANY SNAPSHOT (2024)
FIGURE 63 BIO-TECHNE: COMPANY SNAPSHOT (2023)
FIGURE 64 PACBIO: COMPANY SNAPSHOT (2024)
FIGURE 65 BRUKER: COMPANY SNAPSHOT (2024)
FIGURE 66 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024)

Product Code: BT 4224

The single-cell analysis market is projected to reach USD 7.56 billion by 2030 from an estimated USD 3.81 billion in 2025, at a CAGR of 14.7% during the forecast period. This market growth is largely driven by the increasing emphasis on personalized medicine. Rising research & development investments in the pharmaceutical and biotechnology industries also contribute to the expansion of single-cell analysis. Additionally, factors such as growth in stem cell research and advancements in single-cell analysis technologies are expected to further boost the market. Furthermore, the increasing incidence of cancer is creating a demand for advanced therapies, which is anticipated to enhance the growth of the single-cell analysis market. The rising adoption of advanced single-cell sequencing techniques is also expected to propel market growth in the coming years.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2024-2030
Units Considered	Value (USD billion)
Segments	Product, Cell Type, Technique, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

"The research applications segment accounted for the largest share of the market segment in 2024."

The single-cell analysis market is divided into two main categories based on applications: research and medical applications. The research application segment includes various fields such as cancer research, immunology research, neurology research, stem cell research, and other related areas. In contrast, the medical applications segment is further divided into non-invasive prenatal diagnosis, in vitro fertilization, and circulating tumor cell detection.

In 2024, the research applications segment held the largest share of the global single-cell analysis market. The increasing prevalence of cancer is driving the demand for advanced therapies, which contributes to the growth of this segment. Additionally, the expansion of stem cell research is also expected to further boost the growth of the single-cell analysis market.

"The flow cytometry segment accounted for a major share of the market in 2024."

The single-cell analysis market is categorized based on technology into several segments: flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. In 2024, the flow cytometry segment was the largest contributor to the global single-cell analysis market by technology. This significant growth is primarily due to the widespread use of flow cytometry in single-cell analysis, as it can perform multiple measurements within a heterogeneous mixture. Furthermore, the increasing adoption of advanced cell identification and characterization technologies is expected to further drive growth in this segment of the single-cell analysis market.

"The US dominated the single-cell analysis market in 2024."

The single-cell analysis market is divided into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2024, the US dominated this market in North America. As the world's largest biopharmaceutical market, the US leads in biopharmaceutical research and investments. Its robust healthcare infrastructure further supports research & development in the life sciences sector. Additionally, the presence of numerous biopharmaceutical companies and increasing research activities in the biotechnology industry are contributing to market growth in the US. Furthermore, the rising focus on developing personalized medicine, driven by the increasing incidence of cancer, is also boosting the growth of the single-cell analysis market.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side (70%) and Demand Side (30%)
By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and Middle East & Africa (5%)

List of Companies Profiled in the Report:

Thermo Fisher Scientific Inc. (US)
Danaher Corporation (US)
Merck KGaA (Germany)
BD (US)
Agilent Technologies, Inc. (US)
QIAGEN (Netherlands)
10x Genomics (US)
Illumina, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
DiaSorin S.p.A. (Italy)
Standard BioTools (US)
Tecan Trading AG (Switzerland)
Sartorius AG (Germany)
Corning Incorporated (US)
Cytek Biosciences (US)
Takara Bio Inc. (Japan)
bioMerieux (France)
Revvity (US)
Bio-Techne (US)
PacBio (US)
Bruker (US)
Promega Corporation (US)
Oxford Nanopore Technologies plc. (UK)
The Menarini Group (Italy)
Singleron Biotechnologies (Germany)
BICO (Sweden)
Fluent BioSciences (US)
RareCyte, Inc. (US)
Cell Microsystems (US)
NanoCellect Biomedical (US)
Apogee Flow Systems Ltd. (UK)
Creative Biolabs (US)
Sphere Bio (UK)
Yokogawa Electric Corporation (Japan)

Research Coverage:

This research report categorizes the single-cell analysis market by product {consumables [reagents, assay kits (immunoassays and cell-based assays), beads, microplates, and other consumables] and instruments (PCR instruments, NGS systems, flow cytometers, spectrophotometers, cell counters, microscopes, HCS systems, microarrays, and other instruments)}, cell type (human cells, animal cells, and microbial cells), technique (flow cytometry, next-generation sequencing, microscopy, polymerase chain reaction, mass spectrometry, and other techniques), application [research applications (cancer research, immunology research, neurology research, stem cell research, and other research applications) and medical applications (non-invasive prenatal diagnosis, in vitro fertilization, and circulating tumour cell detection)], end user (academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-cell analysis market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations, acquisitions, and recent developments associated with the single-cell analysis market.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing the closest approximations of the revenue numbers for the overall single-cell analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (technological advancements in single-cell analysis products, the surge in cases of cancer, and increasing R&D in pharmaceutical & biotechnology industries for complex diseases), restraints (high cost of single-cell analysis products), opportunities (integration of microfluidics in single-cell analysis), and challenges (standardization of protocols and data integration & quality control for developing cell therapies) influencing the growth of the market
Product Development/Innovation: Detailed insights on newly launched products of the single-cell analysis market
Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-cell analysis market
Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), BD (US), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), 10x Genomics (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), DiaSorin S.p.A. (Italy), Standard BioTools (US), Tecan Trading AG (Switzerland), Sartorius AG (Germany), Corning Incorporated (US), Cytek Biosciences (US), Takara Bio Inc. (Japan), bioMerieux (France), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Oxford Nanopore Technologies plc. (UK), The Menarini Group (Italy), Singleron Biotechnologies (Germany), BICO (Sweden), Fluent BioSciences (US), RareCyte, Inc. (US), Cell Microsystems (US), NanoCellect Biomedical (US), Apogee Flow Systems Ltd. (UK), Creative Biolabs (US) Sphere Bio (UK), and Yokogawa Electric Corporation (Japan)

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
- 1.3.2 YEARS CONSIDERED
- 1.3.3 INCLUSIONS AND EXCLUSIONS
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION METHODOLOGY
- 2.2.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION
- 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
- 2.2.3 TOP-DOWN APPROACH
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SINGLE-CELL ANALYSIS MARKET
4.2 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE AND COUNTRY
4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030
4.4 SINGLE-CELL ANALYSIS MARKET, BY END USER
4.5 SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Technological advancements in single-cell analysis products
  - 5.2.1.2 Rising prevalence of cancer
  - 5.2.1.3 Increasing R&D in pharmaceutical and biotechnology industries
  - 5.2.1.4 Growth in stem cell research
  - 5.2.1.5 Growing focus on personalized medicine
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High cost of single-cell analysis products
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 High growth potential of single-cell sequencing
  - 5.2.3.2 Integration of microfluidics in single-cell analysis
  - 5.2.3.3 Rising potential in emerging Asian markets
- 5.2.4 CHALLENGES
  - 5.2.4.1 Lack of standardization in protocols and quality control procedures
  - 5.2.4.2 Technical limitations of single-cell analysis
  - 5.2.4.3 Mounting ethical and privacy concerns
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 TECHNOLOGY ANALYSIS
- 5.6.1 KEY TECHNOLOGIES
  - 5.6.1.1 Flow cytometry
  - 5.6.1.2 Next-generation sequencing
  - 5.6.1.3 Polymerase chain reaction
  - 5.6.1.4 Microscopy
  - 5.6.1.5 Mass spectrometry
- 5.6.2 COMPLEMENTARY TECHNOLOGIES
  - 5.6.2.1 Bioinformatics tools and computational analysis
  - 5.6.2.2 Multi-omics integration
- 5.6.3 ADJACENT TECHNOLOGIES
  - 5.6.3.1 Nanotechnology
  - 5.6.3.2 Artificial intelligence and machine learning
5.7 PATENT ANALYSIS
- 5.7.1 METHODOLOGY
- 5.7.2 PATENTS APPLIED AND GRANTED, 2014-2024
5.8 TRADE ANALYSIS
- 5.8.1 IMPORT DATA (HS CODE 9027)
- 5.8.2 EXPORT DATA (HS CODE 9027)
5.9 PORTER'S FIVE FORCES ANALYSIS
- 5.9.1 THREAT OF NEW ENTRANTS
- 5.9.2 THREAT OF SUBSTITUTES
- 5.9.3 BARGAINING POWER OF SUPPLIERS
- 5.9.4 BARGAINING POWER OF BUYERS
- 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 TARIFF & REGULATORY LANDSCAPE
- 5.10.1 TARIFF DATA (HS CODE 9027)
- 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.10.3 REGULATORY FRAMEWORK
5.11 PRICING ANALYSIS
- 5.11.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS
- 5.11.2 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION
5.12 KEY CONFERENCES AND EVENTS, 2025-2026
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
- 5.13.3 BUYING CRITERIA
5.14 INVESTMENT AND FUNDING SCENARIO
5.15 IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET
- 5.15.1 AI USE-CASES
- 5.15.2 KEY COMPANIES IMPLEMENTING AI
5.16 CASE STUDY ANALYSIS
- 5.16.1 COMPREHENSIVE SINGLE-CELL TRANSCRIPTOMIC ATLAS OF HUMAN CORNEA
- 5.16.2 MASSIVELY PARALLEL SINGLE-CELL RNA SEQUENCING IDENTIFIES RARE DRUG-RESISTANT CANCER SUBPOPULATIONS
- 5.16.3 SINGLE-CELL ANALYSIS OF RENAL CELL CARCINOMA REVEALS TUMOR HETEROGENEITY AND MICROENVIRONMENTAL COMPLEXITY
5.17 US 2025 TARIFF IMPACT OVERVIEW
- 5.17.1 INTRODUCTION
- 5.17.2 KEY TARIFF RATES
- 5.17.3 PRICE IMPACT ANALYSIS
- 5.17.4 KEY IMPACT ON VARIOUS REGIONS
  - 5.17.4.1 US
  - 5.17.4.2 Europe
  - 5.17.4.3 Asia Pacific
  - 5.17.4.4 Rest of the World
- 5.17.5 END-USE INDUSTRY IMPACT
  - 5.17.5.1 Pharmaceutical and biotech companies
  - 5.17.5.2 Contract research organizations (CROs)
  - 5.17.5.3 Academic & research institutes

6 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION

6.1 INTRODUCTION
6.2 RESEARCH APPLICATIONS
- 6.2.1 CANCER RESEARCH
  - 6.2.1.1 Rising prevalence of cancer to drive market
- 6.2.2 IMMUNOLOGY RESEARCH
  - 6.2.2.1 High incidence of immunological disorders to propel market
- 6.2.3 NEUROLOGY RESEARCH
  - 6.2.3.1 Increasing incidence of neurological disorders to boost market
- 6.2.4 STEM CELL RESEARCH
  - 6.2.4.1 Rising investments in stem cell research to drive market
- 6.2.5 OTHER RESEARCH APPLICATIONS
6.3 MEDICAL APPLICATIONS
- 6.3.1 NON-INVASIVE PRENATAL DIAGNOSIS
  - 6.3.1.1 Increasing prevalence of genetic diseases to drive demand
- 6.3.2 IN VITRO FERTILIZATION
  - 6.3.2.1 Growing demand for IVF procedures to support market
- 6.3.3 CIRCULATING TUMOR CELL DETECTION
  - 6.3.3.1 Rising prevalence of cancer to contribute to segment growth

7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE

7.1 INTRODUCTION
7.2 HUMAN CELLS
- 7.2.1 GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND
7.3 ANIMAL CELLS
- 7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET
7.4 MICROBIAL CELLS
- 7.4.1 RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET

8 SINGLE-CELL ANALYSIS MARKET, BY END USER

8.1 INTRODUCTION
8.2 ACADEMIC & RESEARCH LABORATORIES
- 8.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
8.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
- 8.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES
- 8.4.1 HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND
8.5 CELL BANKS & IVF CENTERS
- 8.5.1 RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET

9 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT

9.1 INTRODUCTION
9.2 CONSUMABLES
- 9.2.1 BEADS
  - 9.2.1.1 Increasing use in research and genetic exploration to drive market
- 9.2.2 MICROPLATES
  - 9.2.2.1 Rising frequency of product launches to boost market
- 9.2.3 REAGENTS
  - 9.2.3.1 Advancements in single-cell genomics to increase demand
- 9.2.4 ASSAY KITS
  - 9.2.4.1 Immunoassays
    - 9.2.4.1.1 Growth in geriatric population to fuel demand
  - 9.2.4.2 Cell-based assays
    - 9.2.4.2.1 Increasing use in pharma and biopharma companies to drive market
- 9.2.5 OTHER CONSUMABLES
9.3 INSTRUMENTS
- 9.3.1 FLOW CYTOMETERS
  - 9.3.1.1 Technological advancements to drive demand
- 9.3.2 NGS SYSTEMS
  - 9.3.2.1 Increased affordability to support segment growth
- 9.3.3 PCR INSTRUMENTS
  - 9.3.3.1 Rising use for DNA and mRNA amplification to boost market
- 9.3.4 SPECTROPHOTOMETERS
  - 9.3.4.1 Technological advancements to boost market
- 9.3.5 CELL COUNTERS
  - 9.3.5.1 Rising demand for automated cell counters to fuel market
- 9.3.6 MICROSCOPES
  - 9.3.6.1 Increasing use in cell-based research to drive market
- 9.3.7 HCS SYSTEMS
  - 9.3.7.1 Growing need for multi-parametric cell analysis to drive adoption
- 9.3.8 MICROARRAYS
  - 9.3.8.1 Increasing development of targeted therapies to support market
- 9.3.9 OTHER INSTRUMENTS

10 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE

10.1 INTRODUCTION
10.2 FLOW CYTOMETRY
- 10.2.1 INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET
10.3 NEXT-GENERATION SEQUENCING
- 10.3.1 WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET
10.4 POLYMERASE CHAIN REACTION
- 10.4.1 INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET
10.5 MICROSCOPY
- 10.5.1 FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET
10.6 MASS SPECTROMETRY
- 10.6.1 LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET
10.7 OTHER TECHNIQUES

11 SINGLE-CELL ANALYSIS MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
- 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 11.2.2 US
  - 11.2.2.1 Increasing R&D investments and funding to drive market
- 11.2.3 CANADA
  - 11.2.3.1 High prevalence of hemophilia to propel market
11.3 EUROPE
- 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 11.3.2 GERMANY
  - 11.3.2.1 Growing awareness of advanced cell therapies to support market
- 11.3.3 UK
  - 11.3.3.1 Growing adoption of single-cell analysis products to drive demand
- 11.3.4 FRANCE
  - 11.3.4.1 Growing government funding for R&D to propel market
- 11.3.5 ITALY
  - 11.3.5.1 Focus on cell biology research to drive market
- 11.3.6 SPAIN
  - 11.3.6.1 Increasing number of biotechnology companies to drive demand
- 11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
- 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 11.4.2 CHINA
  - 11.4.2.1 Increasing R&D expenditure to support market
- 11.4.3 JAPAN
  - 11.4.3.1 Increasing geriatric population to fuel demand
- 11.4.4 INDIA
  - 11.4.4.1 Growing focus on development of cell-based therapies to boost market
- 11.4.5 SOUTH KOREA
  - 11.4.5.1 Increasing number of strategic alliances to boost market
- 11.4.6 AUSTRALIA
  - 11.4.6.1 Rising number of life science companies to boost demand
- 11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
- 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 11.5.2 BRAZIL
  - 11.5.2.1 Rising focus on biotechnology industry to bolster market
- 11.5.3 MEXICO
  - 11.5.3.1 Government support for biopharmaceutical production to drive market
- 11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST
- 11.6.1 MACROECONOMIC OUTLOOK IN MIDDLE EAST
- 11.6.2 GCC
  - 11.6.2.1 Saudi Arabia
    - 11.6.2.1.1 Increasing healthcare expenditure to drive market
  - 11.6.2.2 United Arab Emirates
    - 11.6.2.2.1 Advancements in biopharmaceutical sector to drive demand
  - 11.6.2.3 Rest of GCC
- 11.6.3 REST OF MIDDLE EAST
11.7 AFRICA
- 11.7.1 GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET
- 11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025
12.3 REVENUE ANALYSIS, 2022-2024
12.4 MARKET SHARE ANALYSIS, 2024
- 12.4.1 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 12.5.1 STARS
- 12.5.2 EMERGING LEADERS
- 12.5.3 PERVASIVE PLAYERS
- 12.5.4 PARTICIPANTS
- 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 12.5.5.1 Company footprint
  - 12.5.5.2 Product footprint
  - 12.5.5.3 Region footprint
  - 12.5.5.4 Technique footprint
  - 12.5.5.5 Application footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.6.1 PROGRESSIVE COMPANIES
- 12.6.2 RESPONSIVE COMPANIES
- 12.6.3 DYNAMIC COMPANIES
- 12.6.4 STARTING BLOCKS
- 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 12.6.5.1 Detailed list of key startups/SMEs
  - 12.6.5.2 Competitive benchmarking of key startups/SMEs
12.7 COMPANY VALUATION AND FINANCIAL METRICS
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
- 12.9.1 PRODUCT LAUNCHES
- 12.9.2 DEALS
- 12.9.3 EXPANSIONS

13 COMPANY PROFILES

13.1 INTRODUCTION
13.2 KEY PLAYERS
- 13.2.1 BD
  - 13.2.1.1 Business overview
  - 13.2.1.2 Products offered
  - 13.2.1.3 Recent developments
    - 13.2.1.3.1 Product launches
    - 13.2.1.3.2 Deals
  - 13.2.1.4 MnM view
    - 13.2.1.4.1 Key strengths
    - 13.2.1.4.2 Strategic choices
    - 13.2.1.4.3 Weaknesses and competitive threats
- 13.2.2 THERMO FISHER SCIENTIFIC INC.
  - 13.2.2.1 Business overview
  - 13.2.2.2 Products offered
  - 13.2.2.3 Recent developments
    - 13.2.2.3.1 Product launches
    - 13.2.2.3.2 Deals
  - 13.2.2.4 MnM view
    - 13.2.2.4.1 Key strengths
    - 13.2.2.4.2 Strategic choices
    - 13.2.2.4.3 Weaknesses and competitive threats
- 13.2.3 DANAHER CORPORATION
  - 13.2.3.1 Business overview
  - 13.2.3.2 Products offered
  - 13.2.3.3 Recent developments
    - 13.2.3.3.1 Deals
  - 13.2.3.4 MnM view
    - 13.2.3.4.1 Key strengths
    - 13.2.3.4.2 Strategic choices
    - 13.2.3.4.3 Weaknesses and competitive threats
- 13.2.4 10X GENOMICS
  - 13.2.4.1 Business overview
  - 13.2.4.2 Products offered
  - 13.2.4.3 Recent developments
    - 13.2.4.3.1 Product launches
    - 13.2.4.3.2 Deals
- 13.2.5 MERCK KGAA
  - 13.2.5.1 Business overview
  - 13.2.5.2 Products offered
  - 13.2.5.3 Recent developments
    - 13.2.5.3.1 Deals
- 13.2.6 AGILENT TECHNOLOGIES, INC.
  - 13.2.6.1 Business overview
  - 13.2.6.2 Products offered
  - 13.2.6.3 Recent developments
    - 13.2.6.3.1 Product launches
    - 13.2.6.3.2 Deals
- 13.2.7 QIAGEN
  - 13.2.7.1 Business overview
  - 13.2.7.2 Products offered
  - 13.2.7.3 Recent developments
    - 13.2.7.3.1 Deals
- 13.2.8 ILLUMINA, INC.
  - 13.2.8.1 Business overview
  - 13.2.8.2 Products offered
  - 13.2.8.3 Recent developments
    - 13.2.8.3.1 Product launches
    - 13.2.8.3.2 Deals
- 13.2.9 BIO-RAD LABORATORIES, INC.
  - 13.2.9.1 Business overview
  - 13.2.9.2 Products offered
  - 13.2.9.3 Recent developments
    - 13.2.9.3.1 Product launches
- 13.2.10 DIASORIN S.P.A.
  - 13.2.10.1 Business overview
  - 13.2.10.2 Products offered
  - 13.2.10.3 Recent developments
    - 13.2.10.3.1 Deals
- 13.2.11 STANDARD BIOTOOLS
  - 13.2.11.1 Business overview
  - 13.2.11.2 Product offered
  - 13.2.11.3 Recent developments
    - 13.2.11.3.1 Product launches
    - 13.2.11.3.2 Deals
- 13.2.12 TECAN TRADING AG
  - 13.2.12.1 Business overview
  - 13.2.12.2 Products offered
  - 13.2.12.3 Recent developments
    - 13.2.12.3.1 Product launches
    - 13.2.12.3.2 Deals
- 13.2.13 SARTORIUS AG
  - 13.2.13.1 Business overview
  - 13.2.13.2 Products offered
  - 13.2.13.3 Recent developments
    - 13.2.13.3.1 Deals
    - 13.2.13.3.2 Expansions
- 13.2.14 CORNING INCORPORATED
  - 13.2.14.1 Business overview
  - 13.2.14.2 Products offered
- 13.2.15 CYTEK BIOSCIENCES
  - 13.2.15.1 Business overview
  - 13.2.15.2 Products offered
  - 13.2.15.3 Recent developments
    - 13.2.15.3.1 Product launches
    - 13.2.15.3.2 Deals
    - 13.2.15.3.3 Expansions
- 13.2.16 TAKARA BIO INC.
  - 13.2.16.1 Business overview
  - 13.2.16.2 Products offered
  - 13.2.16.3 Recent developments
    - 13.2.16.3.1 Product launches
    - 13.2.16.3.2 Deals
- 13.2.17 BIOMERIEUX
  - 13.2.17.1 Business overview
  - 13.2.17.2 Products offered
  - 13.2.17.3 Recent developments
    - 13.2.17.3.1 Deals
- 13.2.18 REVVITY
  - 13.2.18.1 Business overview
  - 13.2.18.2 Products offered
  - 13.2.18.3 Recent developments
    - 13.2.18.3.1 Deals
- 13.2.19 BIO-TECHNE
  - 13.2.19.1 Business overview
  - 13.2.19.2 Products offered
  - 13.2.19.3 Recent developments
    - 13.2.19.3.1 Deals
- 13.2.20 PACBIO
  - 13.2.20.1 Business overview
  - 13.2.20.2 Products offered
  - 13.2.20.3 Recent developments
    - 13.2.20.3.1 Product launches
- 13.2.21 BRUKER
  - 13.2.21.1 Business overview
  - 13.2.21.2 Products offered
  - 13.2.21.3 Recent developments
    - 13.2.21.3.1 Product launches
    - 13.2.21.3.2 Deals
- 13.2.22 PROMEGA CORPORATION
  - 13.2.22.1 Business overview
  - 13.2.22.2 Products offered
- 13.2.23 OXFORD NANOPORE TECHNOLOGIES PLC
  - 13.2.23.1 Business overview
  - 13.2.23.2 Products offered
  - 13.2.23.3 Recent developments
    - 13.2.23.3.1 Deals
13.3 OTHER PLAYERS
- 13.3.1 SINGLERON BIOTECHNOLOGIES
- 13.3.2 CELL MICROSYSTEMS
- 13.3.3 NANOCELLECT BIOMEDICAL
- 13.3.4 RARECYTE, INC.
- 13.3.5 BICO
- 13.3.6 MENARINI GROUP
- 13.3.7 APOGEE FLOW SYSTEMS LTD
- 13.3.8 CREATIVE BIOLABS
- 13.3.9 SPHERE BIO
- 13.3.10 YOKOGAWA ELECTRIC CORPORATION

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

シングルセル解析の世界市場：用途別、細胞タイプ別、エンドユーザー別、製品別、手法別、地域別 - 2030年までの予測

Single Cell Analysis Market by Product (Consumables, Instruments), Cell Type, Technique, Application (Research, Medical ) - Global Forecast to 2030

目次

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場概要

第6章シングルセル解析市場（用途別）

第7章シングルセル解析市場（細胞タイプ別）

第8章シングルセル解析市場（エンドユーザー別）

第9章シングルセル解析市場（製品別）

第10章シングルセル解析市場（手法別）

第11章シングルセル解析市場（地域別）

第12章競合情勢

第13章企業プロファイル

第14章付録

List of Tables

List of Figures

The primary interviews conducted for this report can be categorized as follows:

List of Companies Profiled in the Report:

Research Coverage:

Key Benefits of Buying the Report:

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION

7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE

8 SINGLE-CELL ANALYSIS MARKET, BY END USER

9 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT

10 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE

11 SINGLE-CELL ANALYSIS MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

シングルセル解析の世界市場：用途別、細胞タイプ別、エンドユーザー別、製品別、手法別、地域別 - 2030年までの予測

Single Cell Analysis Market by Product (Consumables, Instruments), Cell Type, Technique, Application (Research, Medical ) - Global Forecast to 2030

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

第6章 シングルセル解析市場（用途別）

第7章 シングルセル解析市場（細胞タイプ別）

第8章 シングルセル解析市場（エンドユーザー別）

第9章 シングルセル解析市場（製品別）

第10章 シングルセル解析市場（手法別）

第11章 シングルセル解析市場（地域別）

第12章 競合情勢

第13章 企業プロファイル

第14章 付録

List of Tables

List of Figures

The primary interviews conducted for this report can be categorized as follows:

List of Companies Profiled in the Report:

Research Coverage:

Key Benefits of Buying the Report:

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION

7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE

8 SINGLE-CELL ANALYSIS MARKET, BY END USER

9 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT

10 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE

11 SINGLE-CELL ANALYSIS MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場概要

第6章シングルセル解析市場（用途別）

第7章シングルセル解析市場（細胞タイプ別）

第8章シングルセル解析市場（エンドユーザー別）

第9章シングルセル解析市場（製品別）

第10章シングルセル解析市場（手法別）

第11章シングルセル解析市場（地域別）

第12章競合情勢

第13章企業プロファイル

第14章付録